Eli Lily Q2 Earnings Preview: Future Depends on Mounjaro and Zepbound Performance

Investing_ng | 07-08-2025 07:46pm |

Market Analysis by covering: Eli Lilly and Company, Capital Partners SA, Novo Nordisk A/S. Read 's Market Analysis on Investing.com NG.

Related Articles

WORLD BANK TO FG...Use Oil Wealth For Ni... Top
2027: ‘Everybody knows’ – Momodu s... Top
Recapitalisation: Five banks’ shares o... Top
Naira gains N88.35 in official FX market... Top
Seplat: ESG, Regulatory Frameworks Drive... Business
NADDC, CFAO, Mikano Motors, Others Back ... Business

Stay Updated with the Latest News!

Don't miss out on breaking stories and in-depth articles.

See the latest News